Table 2.
Quantification of several phase II biotransformation enzymes
Enzyme | Median | Mean ± SD | CV | Range | n a |
---|---|---|---|---|---|
pmol/mg | pmol/mg | % | (min–max) | ||
pmol/mg | |||||
Uridine‐5′‐diphospho (UDP)‐glucuronosyltransferase | |||||
UGT1A1 | 0.63 | 1.30 ± 1.71 | 131 | 0.14–6.49 | 12 |
UGT1A6 | 0.79 | 0.94 ± 0.59 | 62.9 | 0.30–1.72 | 3 |
UGT1A10 | 0.87 | 0.98 ± 0.60 | 61.6 | 0.37–2.46 | 15 |
UGT2A3 | 1.89 | 2.23 ± 1.60 | 71.6 | 0.64–6.92 | 16 |
UGT2B7 | 0.60 | 1.39 ± 1.82 | 131 | 0.01–5.70 | 14 |
UGT2B17 | 6.74 | 7.91 ± 6.71 | 84.9 | 1.45–29.8 | 16 |
Transferase, thioredoxin, and phosphatase enzymes | |||||
GSTA2 | 14.4 | 15.7 ± 7.49 | 47.9 | 5.27–30.6 | 15 |
GSTK1 | 6.55 | 7.23 ± 3.31 | 45.7 | 3.38–15.6 | 16 |
GSTM2 | 0.98 | 1.59 ± 1.59 | 100 | 0.38–6.76 | 16 |
GSTM4 | 0.24 | 0.74 ± 1.11 | 150 | 0.01–3.58 | 13 |
GSTO1 | 6.76 | 7.31 ± 2.98 | 40.7 | 3.25–13.8 | 16 |
GSTP1 | 30.6 | 34.6 ± 15.6 | 45.1 | 17.7–67.3 | 16 |
SULT1A2 | 1.49 | 1.69 ± 1.21 | 71.5 | 0.16–4.27 | 16 |
SULT1A3 | 2.99 | 3.04 ± 2.07 | 68.1 | 0.23–6.25 | 8 |
SULT1B1 | 5.47 | 6.25 ± 2.72 | 43.5 | 2.90–10.7 | 16 |
SULT1E1 | 0.21 | 0.29 ± 0.20 | 70.1 | 0.03–0.61 | 13 |
SULT2A1 | 3.95 | 3.95 ± 3.02 | 76.5 | 0.33–11.0 | 16 |
MGST2 | 4.87 | 5.98 ± 3.19 | 53.3 | 1.18–12.2 | 16 |
MGST3 | 5.40 | 5.69 ± 3.62 | 63.6 | 0.40–15.9 | 16 |
TXN | 34.5 | 31.6 ± 12.2 | 39.0 | 13.9–60.3 | 16 |
ALPI | 3.07 | 3.89 ± 3.52 | 90.5 | 0.49–13.7 | 16 |
Six UGTs (uridine‐5′‐diphospho (UDP)‐glucuronosyltransferases), six GSTs (glutathione S‐transferases), two MGSTs (microsomal glutathione S‐transferases), five SULTs (sulfotransferases), one redox enzyme (TXN, thioredoxin) and one intestinal alkaline phosphatase (ALPI) in human intestine mucosal fractions. Protein expression is represented as a median, mean ± SD (standard deviation), % CV (% coefficient of variation) and range (min–max). Abundance of enzymes is expressed in pmol/mg of intestine mucosal protein.
max, maximum; min, minimum.
Number of human intestine samples.